한글목차

세계 생명과학 IT 시장은 2023년에 213억 달러로 평가되었고, 2024년부터 2033년에 걸쳐 CAGR 11%로 성장하여 2033년에는 625억 달러에 달할 것으로 예측되고 있습니다.

생명과학 IT는 제약, 생명공학, 헬스케어 등 생명과학 분야에서 정보기술의 응용입니다. 이 IT의 전문 분야는 R&D부터 제조, 환자 관리에 이르기까지 생명과학 산업의 다양한 측면을 지원하고 발전시키는 데 매우 중요한 역할을 합니다. 생명과학 IT 소프트웨어 및 서비스는 과학자와 조사자들이 엄청난 양의 생물학적 및 화학적 데이터를 관리할 수 있도록 해주며 생명과학 연구의 다양한 측면을 쉽게 분석할 수 있습니다. 이 기술은 신약에 매우 중요하며 잠재적 치료 표적을 식별하고 신약 개발을 효율화하는 데 도움이 됩니다.

생명과학 IT 시장은 생명과학 산업에서 생명과학 분석 소프트웨어의 채용 증가와 실험실 자동화 동향 증가로 인해 큰 성장이 예상됩니다.

생명 과학 분석 소프트웨어의 채용 증가는 생명 과학 IT 시장의 주요 촉진요인으로 부상하고 있습니다. 이는 첨단 분석이 R&D 프로세스 강화, 비즈니스 효율성 최적화, 데이터 중심의 의사결정 촉진에 있어 중요한 역할에 대한 인식이 높아지기 때문입니다. 분석 소프트웨어는 생명과학 기업이 빅 데이터와 복잡한 데이터 세트의 힘을 활용할 수 있게 함으로써 연구자와 과학자들이 엄청난 정보로부터 의미 있는 통찰력을 끌어낼 수 있도록 합니다.

첨단 분석 툴의 통합은 창약 개발 프로세스를 대폭 합리화하여 보다 정확한 표적 동정, 생물학적 경로의 보다 깊은 이해, 임상시험 설계의 가속이 가능하게 되었습니다. 예를 들어, National Library of Medicine의 2020년 보고서에 따르면, 빅데이터는 임상 연구 및 생물학적 데이터에 견인되는 다른 연구 분야에서 인정되고 있습니다. 또한 분석 소프트웨어는 실시간 모니터링 및 보고를 용이하게 하기 위해 규제 준수를 보장하는 데 중요한 역할을 하여 연구 데이터의 전반적인 품질과 무결성을 향상시킵니다.

또한, 실험실 자동화를 위한 동향 증가는 생명 과학 IT 시장 성장의 주요 촉진요인으로 작용할 것으로 예상됩니다. 생명 과학 IT 솔루션은 생명 과학 연구자와 전문가가 직면한 독특한 과제를 해결하기 위해 설계되었으며, 실험실 워크플로우의 다양한 측면을 통합하고 최적화하는 종합적인 플랫폼을 제공합니다. 실험실 자동화 소프트웨어의 주요 장점 중 하나는 데이터 관리에 있으며, 이러한 소프트웨어 시스템은 엄청난 복잡한 과학 데이터의 원활한 구성, 저장 및 검색을 용이하게 합니다. 이는 데이터의 정확성을 높일 뿐만 아니라 수작업으로 인한 실수를 줄이고 관리 작업에 소요되는 시간을 줄임으로써 연구 속도를 가속화합니다.

또한 생명과학 IT 솔루션은 샘플 추적 및 실험 실행부터 데이터 분석에 이르기까지 실험실 프로세스 자동화에 크게 기여하고 있습니다. 예를 들어, 생명 과학 솔루션의 세계 기업인 Thermofisher Scientific은 실험실 자동화를 위한 워크플로 스케줄링 소프트웨어 Momentum을 제공합니다. 이 소프트웨어는 강력하고 사용하기 쉬운 시각적 환경으로 과학적 프로세스와 워크플로우를 정의, 실행 및 모니터링할 수 있습니다. 직관적 인 스케줄링 인터페이스, 지능형 데이터 기반 의사 결정 기능, 우수한 연결성 및 유연한 시뮬레이션 모드는 뛰어난 성능을 달성하는 데 도움이 됩니다.

자동화는 작업을 가속화할 뿐만 아니라 실험의 일관성과 반복성을 보장합니다. 따라서 실험실 자동화를 위한 동향 증가는 시장 성장에 크게 기여할 것으로 예상됩니다.

그러나 데이터 보안과 프라이버시에 대한 우려가 시장 성장을 억제하는 주요 우려로 떠오르고 있습니다. 생명과학 업계는 환자 기록, 임상시험 정보, 게놈 데이터 등 기밀성이 높은 방대한 데이터의 수집, 보관, 분석에 크게 의존하고 있습니다. 의료 프로세스의 디지털화가 진행됨에 따라 클라우드 컴퓨팅 및 빅 데이터 분석과 같은 첨단 기술이 채택됨에 따라 데이터 유출 및 무단 액세스의 위험이 커지고 있습니다. 따라서 데이터 보안 및 개인 정보 보호 문제가 시장 성장을 억제할 것으로 예상됩니다.

생명 과학 IT 시장은 솔루션, 유형, 최종 사용자, 지역별로 구분됩니다. 솔루션별로는 의약품 인포매틱스, 임상시험 관리, 바이오인포매틱스, 실험실 정보 관리 등으로 나눌 수 있습니다. 유형별로 소프트웨어 및 서비스로 이분됩니다. 최종 사용자별로는 제약 및 바이오테크놀러지 기업, 연구개발 수탁기관, 기타로 구분됩니다. 지역별로는 북미(미국, 캐나다, 멕시코), 유럽(독일, 프랑스, 영국, 이탈리아, 스페인, 기타 유럽), 아시아태평양(중국, 일본, 호주, 인도, 한국, 기타 아시아태평양), 아시아태평양(브라질, 일본, 아라비아, 호주, 인도, 한국 및 기타 아시아태평양)에서 분석됩니다.

이해관계자를 위한 주요 이점

• 본 보고서에서는 2023년부터 2033년까지의 생명과학 시장 분석 시장 부문, 현재의 동향, 추정·동향 분석, 역학을 정량적으로 분석하여 일반적인 생명 과학 IT 시장의 기회를 파악합니다.
• 시장 성장 촉진요인, 시장 성장 억제요인, 시장 기회와 관련된 정보와 함께 시장 조사를 제공합니다.
• Porter's Five Forces 분석은 이해관계자들이 이익에 중점을 둔 비즈니스 결정을 내리고 공급업체와 구매자의 네트워크를 강화할 수 있도록 구매자와 공급업체의 잠재력을 보여줍니다.
• 생명 과학 시장 세분화의 상세한 분석을 통해 시장 기회를 파악할 수 있습니다.
• 각 지역의 주요 국가는 세계 시장에 대한 수익 공헌도에 따라 매핑됩니다.
• 시장 기업 포지셔닝은 벤치마킹을 용이하게 하고 시장 기업의 현재 위치를 명확하게 이해할 수 있습니다.
• 이 보고서에는 지역별 및 세계 생명 과학 시장 동향, 주요 기업, 시장 부문, 응용 분야 및 시장 성장 전략 분석이 포함되어 있습니다.

이 보고서는 사용자 정의가 가능합니다.

• 규제 가이드라인
• 고객의 관심에 따른 기업 프로파일 추가
• 국가별 또는 지역별 추가 분석 - 시장 규모 및 예측
• 기업 프로파일의 확장 목록
• 과거 시장 데이터
• 주요 기업의 상세(소재지, 연락처, 공급자/벤더 네트워크 등을 포함한 엑셀 형식)

목차

제1장 서론

제2장 주요 요약

제3장 시장 개요

• 시장 정의와 범위
• 주요 조사 결과
  • 영향요인
  • 주요 투자 기회
• Porter's Five Forces 분석
• 시장 역학
  • 성장 촉진요인
    • 실험실 자동화에 대한 동향 증가
    • 고급 분석 도구에 대한 수요 증가
    • 신약 과정에서 생명 과학 IT 솔루션의 높은 채용률
  • 억제요인
    • 데이터 프라이버시 및 보안에 대한 우려
  • 기회
    • 생명 과학 IT 기술의 기술적 진보

제4장 생명 과학 IT 시장 : 솔루션별

• 개요
• 창약 정보학
• 임상시험관리
• 바이오인포매틱스
• 임상 검사 정보 관리
• 기타

제5장 생명과학 IT 시장 : 유형별

• 개요
• 소프트웨어
• 서비스

제6장 생명 과학 IT 시장 : 최종 사용자별

• 개요
• 제약 및 바이오테크놀러지 기업
• 연구개발 수탁기관
• 기타

제7장 생명 과학 IT 시장 : 지역별

• 개요
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 기타
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 기타
• 라틴아메리카, 중동 및 아프리카
  • 브라질
  • 사우디아라비아
  • 남아프리카
  • 기타

제8장 경쟁 구도

• 소개
• 주요 성공 전략
• 주요 10개사의 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝, 2023년

제9장 기업 프로파일

• Thermo Fisher Scientific Inc.
• Qiagen NV.
• Agilent Technologies, Inc.
• Oracle Corporation
• Revvity, Inc.
• Clario
• IBM Corporation
• DNAnexus, Inc.
• Genedata AG
• Illumina, Inc.

영문목차

The global life sciences IT market was valued at $21.3 billion in 2023, and is projected to reach $62.5 billion by 2033, growing at a CAGR of 11% from 2024 to 2033.

Life science IT is the application of information technology in the field of life sciences, including pharmaceuticals, biotechnology, and healthcare. This specialized branch of IT plays a pivotal role in supporting and advancing various aspects of the life sciences industry, from R&D to manufacturing and patient care. Life science IT software and services aid scientists and researchers in managing vast amounts of biological and chemical data, facilitating the analysis of various aspects of life sciences research. This technology is crucial for drug discovery, helping to streamline the identification of potential therapeutic targets and the development of new drugs.

The life science IT market is expected to register significant growth, owing to rise in adoption of life sciences analytical software in life sciences industry, and growing trend towards laboratory automation.

Rise in adoption of the life sciences analytical software has emerged as major driver for the life science IT market. This can be attributed to increasing awareness about the crucial role that advanced analytics plays in enhancing R&D processes, optimizing operational efficiency, and facilitating data-driven decision-making. Analytical software enables life sciences companies to harness the power of big data and complex datasets; thereby empowering researchers and scientists to extract meaningful insights from vast pools of information.

The integration of sophisticated analytics tools has significantly streamlined drug discovery and development processes, allowing for more precise target identification, better understanding of biological pathways, and accelerated clinical trial designs. For instance, according to a 2020 report by National Library of Medicine, big data is gaining recognition in clinical studies and other research areas driven by biological data. Moreover, analytical software plays a crucial role in ensuring regulatory compliance, as it facilitates real-time monitoring and reporting; thereby enhancing the overall quality and integrity of research data.

Furthermore, the growing trend towards the laboratory automation is expected to act as a major driver for the growth of the life science IT market. Life science IT solutions are designed to address the unique challenges faced by life sciences researchers and professionals, offering a comprehensive platform that integrates and optimizes various facets of laboratory workflows. One of the key advantages of laboratory automation software lies in data management, where these software systems facilitate seamless organization, storage, and retrieval of vast volumes of complex scientific data. This not only enhances data accuracy but also accelerates the pace of research by reducing manual errors and the time spent on administrative tasks.

Furthermore, life science IT solutions contribute significantly to the automation of laboratory processes, ranging from sample tracking and experiment execution to data analysis. For instance, Thermo Fisher Scientific Inc., a global life science solution company provides Momentum workflow scheduling software for laboratory automation. It enables users to define, execute, and monitor scientific processes and workflows in a powerful yet easy-to-use visual environment. Its intuitive scheduling interface, intelligent data-driven decision-making capabilities, superior connectivity, and flexible simulation modes help attain superior performance.

Automation not only expedites tasks but also ensures consistency and reproducibility in experiments, which is a crucial factor in maintaining high-quality research standards. Thus, the growing trend towards laboratory automation is expected to contribute significantly in the growth of the market.

However, data security and privacy concerns have emerged as major concerns restraining the growth of the market. The life sciences industry relies heavily on the collection, storage, and analysis of vast amounts of sensitive and confidential data, including patient records, clinical trial information, and genomic data. With increase in digitization of healthcare processes and the adoption of advanced technologies such as cloud computing and big data analytics, the risk of data breaches and unauthorized access has escalated. Thus, data security and privacy concerns are expected to restrain the growth of the market.

The life science IT market is segmented on the basis of solution, type, end user, and region. By solution, it is divided into drug discovery informatics, clinical trial management, bioinformatics, laboratory information management, and others. By type, it is bifurcated into software and services. By end user, it is segmented into pharmaceutical and biotechnology companies, contract R&D organizations, and other. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The major players profiled in the report are Thermo Fisher Scientific Inc, Illumina, Qiagen N.V., Revvity, Inc, Agilent Technologies Inc, Oracle, Clario Inc, IBM Corp, DNAnexus Inc, and Genedata AG.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the life sciences it market analysis from 2023 to 2033 to identify the prevailing life sciences it market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the life sciences it market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global life sciences it market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Solution

• Drug Discovery Informatics
• Clinical Trial Management
• Bioinformatics
• Laboratory Information Management
• Others

By Type

• Software
• Service

By End User

• Others
• Pharmaceutical and Biotechnology Companies
• Contract Research and Development Organizations

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• Thermo Fisher Scientific Inc.
• Qiagen NV.
• Agilent Technologies, Inc.
• Oracle Corporation
• Clario
• IBM Corporation
• Genedata AG
• Illumina, Inc.
• Revvity, Inc.
• DNAnexus, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
  • 3.3.1. Low bargaining power of suppliers
  • 3.3.2. Low threat of new entrants
  • 3.3.3. Low threat of substitutes
  • 3.3.4. Low intensity of rivalry
  • 3.3.5. Low bargaining power of buyers
• 3.4. Market dynamics
  • 3.4.1. Drivers
    • 3.4.1.1. Growing trend towards laboratory automation.
    • 3.4.1.2. Rise in demand for advance analytical tool
    • 3.4.1.3. High adoption of life sciences IT solutions in drug discovery process.
  • 3.4.2. Restraints
    • 3.4.2.1. Data privacy and security concerns
  • 3.4.3. Opportunities
    • 3.4.3.1. Technological advancement in life sciences IT technology

CHAPTER 4: LIFE SCIENCES IT MARKET, BY SOLUTION

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. Drug Discovery Informatics
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
• 4.3. Clinical Trial Management
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country
• 4.4. Bioinformatics
  • 4.4.1. Key market trends, growth factors and opportunities
  • 4.4.2. Market size and forecast, by region
  • 4.4.3. Market share analysis by country
• 4.5. Laboratory Information Management
  • 4.5.1. Key market trends, growth factors and opportunities
  • 4.5.2. Market size and forecast, by region
  • 4.5.3. Market share analysis by country
• 4.6. Others
  • 4.6.1. Key market trends, growth factors and opportunities
  • 4.6.2. Market size and forecast, by region
  • 4.6.3. Market share analysis by country

CHAPTER 5: LIFE SCIENCES IT MARKET, BY TYPE

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Software
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Service
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country

CHAPTER 6: LIFE SCIENCES IT MARKET, BY END USER

• 6.1. Overview
  • 6.1.1. Market size and forecast
• 6.2. Pharmaceutical and Biotechnology Companies
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by region
  • 6.2.3. Market share analysis by country
• 6.3. Contract Research and Development Organizations
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by region
  • 6.3.3. Market share analysis by country
• 6.4. Others
  • 6.4.1. Key market trends, growth factors and opportunities
  • 6.4.2. Market size and forecast, by region
  • 6.4.3. Market share analysis by country

CHAPTER 7: LIFE SCIENCES IT MARKET, BY REGION

• 7.1. Overview
  • 7.1.1. Market size and forecast By Region
• 7.2. North America
  • 7.2.1. Key market trends, growth factors and opportunities
  • 7.2.2. Market size and forecast, by Solution
  • 7.2.3. Market size and forecast, by Type
  • 7.2.4. Market size and forecast, by End User
  • 7.2.5. Market size and forecast, by country
    • 7.2.5.1. U.S.
    • 7.2.5.1.1. Market size and forecast, by Solution
    • 7.2.5.1.2. Market size and forecast, by Type
    • 7.2.5.1.3. Market size and forecast, by End User
    • 7.2.5.2. Canada
    • 7.2.5.2.1. Market size and forecast, by Solution
    • 7.2.5.2.2. Market size and forecast, by Type
    • 7.2.5.2.3. Market size and forecast, by End User
    • 7.2.5.3. Mexico
    • 7.2.5.3.1. Market size and forecast, by Solution
    • 7.2.5.3.2. Market size and forecast, by Type
    • 7.2.5.3.3. Market size and forecast, by End User
• 7.3. Europe
  • 7.3.1. Key market trends, growth factors and opportunities
  • 7.3.2. Market size and forecast, by Solution
  • 7.3.3. Market size and forecast, by Type
  • 7.3.4. Market size and forecast, by End User
  • 7.3.5. Market size and forecast, by country
    • 7.3.5.1. Germany
    • 7.3.5.1.1. Market size and forecast, by Solution
    • 7.3.5.1.2. Market size and forecast, by Type
    • 7.3.5.1.3. Market size and forecast, by End User
    • 7.3.5.2. France
    • 7.3.5.2.1. Market size and forecast, by Solution
    • 7.3.5.2.2. Market size and forecast, by Type
    • 7.3.5.2.3. Market size and forecast, by End User
    • 7.3.5.3. UK
    • 7.3.5.3.1. Market size and forecast, by Solution
    • 7.3.5.3.2. Market size and forecast, by Type
    • 7.3.5.3.3. Market size and forecast, by End User
    • 7.3.5.4. Italy
    • 7.3.5.4.1. Market size and forecast, by Solution
    • 7.3.5.4.2. Market size and forecast, by Type
    • 7.3.5.4.3. Market size and forecast, by End User
    • 7.3.5.5. Spain
    • 7.3.5.5.1. Market size and forecast, by Solution
    • 7.3.5.5.2. Market size and forecast, by Type
    • 7.3.5.5.3. Market size and forecast, by End User
    • 7.3.5.6. Rest of Europe
    • 7.3.5.6.1. Market size and forecast, by Solution
    • 7.3.5.6.2. Market size and forecast, by Type
    • 7.3.5.6.3. Market size and forecast, by End User
• 7.4. Asia-Pacific
  • 7.4.1. Key market trends, growth factors and opportunities
  • 7.4.2. Market size and forecast, by Solution
  • 7.4.3. Market size and forecast, by Type
  • 7.4.4. Market size and forecast, by End User
  • 7.4.5. Market size and forecast, by country
    • 7.4.5.1. Japan
    • 7.4.5.1.1. Market size and forecast, by Solution
    • 7.4.5.1.2. Market size and forecast, by Type
    • 7.4.5.1.3. Market size and forecast, by End User
    • 7.4.5.2. China
    • 7.4.5.2.1. Market size and forecast, by Solution
    • 7.4.5.2.2. Market size and forecast, by Type
    • 7.4.5.2.3. Market size and forecast, by End User
    • 7.4.5.3. India
    • 7.4.5.3.1. Market size and forecast, by Solution
    • 7.4.5.3.2. Market size and forecast, by Type
    • 7.4.5.3.3. Market size and forecast, by End User
    • 7.4.5.4. Australia
    • 7.4.5.4.1. Market size and forecast, by Solution
    • 7.4.5.4.2. Market size and forecast, by Type
    • 7.4.5.4.3. Market size and forecast, by End User
    • 7.4.5.5. South Korea
    • 7.4.5.5.1. Market size and forecast, by Solution
    • 7.4.5.5.2. Market size and forecast, by Type
    • 7.4.5.5.3. Market size and forecast, by End User
    • 7.4.5.6. Rest of Asia-Pacific
    • 7.4.5.6.1. Market size and forecast, by Solution
    • 7.4.5.6.2. Market size and forecast, by Type
    • 7.4.5.6.3. Market size and forecast, by End User
• 7.5. LAMEA
  • 7.5.1. Key market trends, growth factors and opportunities
  • 7.5.2. Market size and forecast, by Solution
  • 7.5.3. Market size and forecast, by Type
  • 7.5.4. Market size and forecast, by End User
  • 7.5.5. Market size and forecast, by country
    • 7.5.5.1. Brazil
    • 7.5.5.1.1. Market size and forecast, by Solution
    • 7.5.5.1.2. Market size and forecast, by Type
    • 7.5.5.1.3. Market size and forecast, by End User
    • 7.5.5.2. Saudi Arabia
    • 7.5.5.2.1. Market size and forecast, by Solution
    • 7.5.5.2.2. Market size and forecast, by Type
    • 7.5.5.2.3. Market size and forecast, by End User
    • 7.5.5.3. South Africa
    • 7.5.5.3.1. Market size and forecast, by Solution
    • 7.5.5.3.2. Market size and forecast, by Type
    • 7.5.5.3.3. Market size and forecast, by End User
    • 7.5.5.4. Rest of LAMEA
    • 7.5.5.4.1. Market size and forecast, by Solution
    • 7.5.5.4.2. Market size and forecast, by Type
    • 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product mapping of top 10 player
• 8.4. Competitive dashboard
• 8.5. Competitive heatmap
• 8.6. Top player positioning, 2023

CHAPTER 9: COMPANY PROFILES

• 9.1. Thermo Fisher Scientific Inc.
  • 9.1.1. Company overview
  • 9.1.2. Key executives
  • 9.1.3. Company snapshot
  • 9.1.4. Operating business segments
  • 9.1.5. Product portfolio
  • 9.1.6. Business performance
• 9.2. Qiagen NV.
  • 9.2.1. Company overview
  • 9.2.2. Key executives
  • 9.2.3. Company snapshot
  • 9.2.4. Operating business segments
  • 9.2.5. Product portfolio
  • 9.2.6. Business performance
  • 9.2.7. Key strategic moves and developments
• 9.3. Agilent Technologies, Inc.
  • 9.3.1. Company overview
  • 9.3.2. Key executives
  • 9.3.3. Company snapshot
  • 9.3.4. Operating business segments
  • 9.3.5. Product portfolio
  • 9.3.6. Business performance
• 9.4. Oracle Corporation
  • 9.4.1. Company overview
  • 9.4.2. Key executives
  • 9.4.3. Company snapshot
  • 9.4.4. Operating business segments
  • 9.4.5. Product portfolio
  • 9.4.6. Business performance
• 9.5. Revvity, Inc.
  • 9.5.1. Company overview
  • 9.5.2. Key executives
  • 9.5.3. Company snapshot
  • 9.5.4. Operating business segments
  • 9.5.5. Product portfolio
  • 9.5.6. Key strategic moves and developments
• 9.6. Clario
  • 9.6.1. Company overview
  • 9.6.2. Key executives
  • 9.6.3. Company snapshot
  • 9.6.4. Operating business segments
  • 9.6.5. Product portfolio
  • 9.6.6. Key strategic moves and developments
• 9.7. IBM Corporation
  • 9.7.1. Company overview
  • 9.7.2. Key executives
  • 9.7.3. Company snapshot
  • 9.7.4. Operating business segments
  • 9.7.5. Product portfolio
  • 9.7.6. Business performance
• 9.8. DNAnexus, Inc.
  • 9.8.1. Company overview
  • 9.8.2. Key executives
  • 9.8.3. Company snapshot
  • 9.8.4. Operating business segments
  • 9.8.5. Product portfolio
  • 9.8.6. Key strategic moves and developments
• 9.9. Genedata AG
  • 9.9.1. Company overview
  • 9.9.2. Key executives
  • 9.9.3. Company snapshot
  • 9.9.4. Operating business segments
  • 9.9.5. Product portfolio
  • 9.9.6. Key strategic moves and developments
• 9.10. Illumina, Inc.
  • 9.10.1. Company overview
  • 9.10.2. Key executives
  • 9.10.3. Company snapshot
  • 9.10.4. Operating business segments
  • 9.10.5. Product portfolio
  • 9.10.6. Business performance